Not available
Quote | IDEXX Laboratories Inc. (NASDAQ:IDXX)
Last: | $494.26 |
---|---|
Change Percent: | 0.92% |
Open: | $489.24 |
Close: | $494.26 |
High: | $497.4 |
Low: | $487.88 |
Volume: | 470,672 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | IDEXX Laboratories Inc. (NASDAQ:IDXX)
2024-04-24 11:25:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Focused Growth Fund increased 1.68% in the first quarter. The Fund underperf...
2024-04-19 11:56:37 ET The selloff in the S&P 500 over the past couple of weeks has pulled certain stocks into what is considered oversold territory, according to the relative strength index technical indicator.... Read the full article on Seeking Alpha For further details s...
Message Board Posts | IDEXX Laboratories Inc. (NASDAQ:IDXX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $IDXX News Article - Groundbreaking IDEXX Study Reveals Opportunities to Increase Veter | whytestocks | investorshangout | 02/20/2023 1:20:47 PM |
whytestocks: $IDXX News Article - IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Res | whytestocks | investorshangout | 02/02/2022 8:25:47 PM |
lol | kclark55 | investorshub | 12/03/2021 8:40:48 PM |
Impressive call. | Hitman970 | investorshub | 08/20/2020 12:12:19 AM |
whytestocks: $IDXX News Article - IDEXX launches groundbreaking new ProCyte One Hematology Analyzer | whytestocks | investorshangout | 08/12/2020 6:40:50 PM |
News, Short Squeeze, Breakout and More Instantly...
IDEXX Laboratories Inc. Company Name:
IDXX Stock Symbol:
NASDAQ Market:
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. ...
Elanco Animal Health Inc (NYSE:ELAN) has reached a settlement with Ancora, enabling it to sidestep a potential proxy fight with the activist i...